Stephen B. Shrewsbury serves as Executive at AVI BIOPHARMA INC, where they oversee executive responsibilities. Since joining the company, Stephen B. Shrewsbury has executed 6 insider transactions totaling $3.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 29, 2022 involved exercising options for 24,606 shares valued at $48.5K.
Stephen B. Shrewsbury currently holds 97,990 shares of AVI BIOPHARMA INC (AVII), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen B. Shrewsbury has been a net buyer of AVII stock. They have purchased $3.3K and sold $0 worth of shares.
Stephen B. Shrewsbury's most recent insider trade was on Mar 29, 2022, when they sold 24,606 shares at $1.97 per share.
Get notified when new Form 4 filings are submitted
| 14,780 |
| $1.97 |
| Discretionary |
| Sep 21, 2021 | IMPL | $11.4K | Option Exercise | 4,650 | $2.46 | Discretionary |
| Sep 21, 2021 | IMPL | $159.2K | Option Exercise | 53,954 | $2.95 | Discretionary |
| Sep 2, 2014 | AQXP | $3.3K | Purchase | 400 | $8.22 | Discretionary |
| Jan 26, 2009 | AVII | $0 | Award | 60,000 | $N/A | Discretionary |